September 2019 HSC Section 1 Congenital and Pediatric Problems

Yuhan et al

75. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long- term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004;110(17):2747–71 . 76. Saguil A, Fargo M, Grogan S. Diagnosis and management of kawasaki disease. Am Fam Physician 2015;91(6):365–71 . 77. Miller RW, Young JL, Novakovic B. Childhood cancer. Cancer 1995;75(1 Suppl): 395–405 . 78. Perez EA, Kassira N, Cheung MC, et al. Rhabdomyosarcoma in children: a SEER population based study. J Surg Res 2011;170(2):e243–51 . 79. Turner JH, Richmon JD. Head and neck rhabdomyosarcoma: a critical analysis of population-based incidence and survival data. Otolaryngol Head Neck Surg 2011;145(6):967–73 . 80. Brady JS, Chung SY, Marchiano E, et al. Pediatric head and neck bone sar- comas: an analysis of 204 cases. Int J Pediatr Otorhinolaryngol 2017;100:71–6 . 81. Qaisi M, Eid I. Pediatric head and neck malignancies. Oral Maxillofac Surg Clin North Am 2016;28(1):11–9 . 82. Patel SG, Meyers P, Huvos AG, et al. Improved outcomes in patients with osteo- genic sarcoma of the head and neck. Cancer 2002;95(7):1495–503 . 83. Huh WW, Holsinger FC, Levy A, et al. Osteosarcoma of the jaw in children and young adults. Head Neck 2012;34(7):981–4 . 84. Guadagnolo BA, Zagars GK, Raymond AK, et al. Osteosarcoma of the jaw/ craniofacial region: outcomes after multimodality treatment. Cancer 2009; 115(14):3262–70 .

200